Fig. 2From: Safety and pharmacodynamic dose response of short-term prednisone in healthy adult subjects: a dose ranging, randomized, placebo-controlled, crossover studyMean change from baseline (difference from placebo) in white blood cell counts. Eosinophil, neutrophil, and lymphocyte counts for Day 1 by hour (a, c, e) and for Days 1 through 8 (b, d, f) for each daily prednisone dose. *P ≤ 0.05 and **P ≤ 0.01 versus placeboBack to article page